Infection with Treponema pallidum subsp. pallidum (T. pallidum), the causative agent of syphilis, leads to a powerful cellular and humoral immune response. Despite this vigorous immune response, T. pallidum is not fully eliminated, as manifested by relapses of secondary syphilis and/or late syphilitic processes. A possible explanation for this incomplete clearance of T. pallidum may be the near lack of antibody binding to the surface of the treponemes. The inaccessibility to antibodies has been appreciated since the studies of Hardy and Nell in 1957 on the nonagglutinability with anti-T. pallidum antibodies of freshly isolated treponemes (8) . The ability of T. pallidum cells to bind a large variety of host proteins (1) is presumed to contribute to this inaccessibility to antibodies.
Studies on the structure of the surface of T. pallidum have been greatly hindered by the inability to cultivate the organism and to separate the outer and inner membranes. However, the extraction of T. pallidum with low concentrations of detergents like sodium dodecyl sulfate (SDS) and Triton X-114 suggests that the outer membrane contains a paucity of proteins (22) . This is consistent with recent observations on freeze-fractured T. pallidum cells which suggest an unusually low density of intramembranous particles in the outer membrane (24, 33) . Although no direct data are available on the structure of the outer surface of T. pallidum, the apparent paucity of proteins likely contributes to the relative inaccessibility of T. pallidum to antibodies.
Another unusual property of T. pallidum is the posttranslational lipidation of many of the major immunogenic mem-* Corresponding author.
brane-associated proteins of T. pallidum (4, 29) . The lipid moiety of lipoproteins likely acts as a membrane anchor, with the hydrophilic peptide part protruding into the periplasmic space, leaving the protein unexposed to the cell surface. At present, it is unclear whether T. pallidum lipoproteins are located in the inner or outer membrane.
At least eight lipid-modified proteins in T. pallidum have been identified, either by direct chemical analysis of whole organisms or detergent phase-partitioned proteins, by the in vivo incorporation of 3H-palmitic acid in T. pallidum proteins, or indirectly by the in vivo lipidation of cloned T. pallidum proteins expressed in Escherichia coli. Although the sequences of four lipoproteins (the 47-kDa protein, TmpA, TpD, and the 15-kDa protein) have been described, only one of these proteins, TmpA, has been overexpressed and purified to homogeneity from E. coli K-12. Therefore, the humoral immune response of a large number of syphilis patients to only TmpA has been investigated (7, 12) . In the present study, we describe the purification of the 35-kDa lipoprotein TmpC and the reactivity of serum samples from syphilis patients to this protein.
The role of the unusually large number of lipoproteins in T. pallidum is unclear. Perhaps these proteins provide the outer membrane with rigidity or other functions without exposing parts of the protein to the surface of the bacterial cell. Thus, lipoproteins would not be accessible to antibodies. It is well known that the lipid moiety on bacterial lipoproteins strongly potentiates the humoral as well as the cellular immune response to the peptide moiety of these proteins (6, 13) . To investigate the role of the lipid part of T. pallidum lipoproteins in the immune response, we constructed and analyzed mutants of T. pallidum lipoproteins, 
MATERIALS AND METHODS
Bacterial strains and plasmids. T. pallidum Nichols was cultivated and isolated as described previously (31) . The E. coli K-12 strains and plasmids used throughout this study are listed in Table 1 .
Media and reagents. NZYM medium and NZYM agar (17), supplemented with ampicillin (100 ,ug/ml in solid medium and 200 pug/ml in liquid medium) and kanamycin (30 ,ug/ml), were used for cultivating E. coli K-12.
The enzymes used in this study were obtained from Boehringer GmbH (Mannheim, Germany), New England Biolabs, Inc. (Beverly, Mass.), or the Pharmacia Molecular Biology Division (Uppsala, Sweden) and were used as recommended by the manufacturers.
[1-14C]palmitic acid (3.7 MBq/ml) was from Dupont, NEN Research Products. The solvent in the palmitic acid solution was removed by evaporation, and the fatty acid was redissolved in 0.4% Triton X-100 to 18.5 MBq/ml.
Immunological techniques. The Western blotting (immunoblotting) technique has been described previously (31) . SDSpolyacrylamide gel electrophoresis (PAGE) was done with 13% polyacrylamide gels as described by Laemmli (16) .
An enzyme-linked immunosorbent assay (ELISA) using TmpC as an antigen was performed similarly to the ELISA with TmpA as an antigen (12) (17) .
The dideoxy chain termination technique for nucleotide sequencing of double-stranded DNA (9, 26) was used to determine the nucleotide sequence of both strands of the DNA. For this purpose, a 1.2-kb fragment from pRIT9070 carrying the tmpC gene was inserted into pEMBL9 to form pRIT9091. The sequence was then determined by using the M13 forward and reverse primers and custom-made oligonucleotides. The DNA sequence of the regions upstream and downstream from the tmpC gene was derived from plasmids pRIT9092 and pRIT9093 by using custom-made oligonucleotides.
The polymerase chain reaction was basically performed by using the protocol and buffers described by Noordhoek et al. (18 log phase was reached. Cells were spun down and resuspended in minimal medium supplemented with 0.05% Casamino Acids, 0.05% yeast extract, and 0.2% glucose. After 20 min of incubation at 28°C, the culture was split into two fractions. One part of the culture was further incubated at 28°C, and the temperature of the other part was raised to 42°C. After 1, 2, and 3 h, respectively, 14C-amino acids (95 GBq/ml, final concentration) were added to the cells and the culture was labeled for 10 min, after which the cells were harvested by centrifugation. Cells were lysed with SDS-PAGE sample buffer and subjected to SDS-PAGE and fluorography.
Construction of plasmids hyperexpressing TmpC. The 45-kb cosmid recombinant pRIT9000 (31) was cut with SalI and religated to give the 11-kb deletion derivative pRIT9001. The pRIT9001 derivatives pRIT9003, pRIT9035, and pRIT9036 were made by complete Clal, partial BstEII, and complete BstEII digestions, respectively. The expression plasmid pRIT9050 was constructed by inserting the 4-kb HindIII fragment of pRIT9001 into the HindIll site of the expression vector pPLc236 (25) . To construct a plasmid with tmpC inversely oriented to the PL promoter, pRIT9050 was partially cut with Aval and cut to completion with HindIII, and the fragment carrying the tmpC gene was inserted into AvaI-and HindIll-cleaved pPLc236. The resulting plasmid was designated pRIT9060. To construct a high-level expression plasmid, pRIT9060 was cut with BamHI and treated with DNA polymerase in a mixture of dTTP, dCTP, dGTP, and sulfonated dATP. The linear plasmid was digested with HindIII, exonuclease Bal 31, and Si nuclease. Because the sulfonated dATP was incorporated at the BamHI end, the nuclease Bal 31 affected only the HindIll end. After religation of the mixture, a number of plasmids with unidirectional deletions were obtained. One of these, pRIT9070, was selected for further study.
Site-directed mutagenesis of leader sequences. To mutagenize the TmpA leader sequence, a 190-bp fragment of plasmid pRIT4661, which carries the tmpA gene (28) , was amplified by the polymerase chain reaction, driven by two oligonucleotides, one with a perfect match upstream from the EcoRI site and one overlapping the cysteine codon in the tmpA gene and the Narl site, but with a mismatch in the codon for cysteine. The mismatch causes a 1-bp mutation resulting in a single amino acid substitution from cysteine to serine (TGT--TCT). The amplified fragment carrying the mutation was then cut with the restriction enzymes EcoRI and NarI and introduced into EcoRI-and NarI-digested pRIT4661. The resulting plasmid was designated pRIT4683.
A similar procedure could not be employed for the mutagenesis of plasmids carrying the tmpC and tpD genes because of the lack of suitable restriction sites close to the mutation. To circumvent this problem, a two-step, PCRmediated, site-directed mutagenesis procedure proposed by Kadowaki et al. (14) , in which a 5' FokI site is located on the oligonucleotide used for mutagenesis, was applied. This procedure was used to mutate the leader sequence in pRIT9070, carrying the tmpC gene, and in pRIT2885, which carries the tpD gene. The mutant plasmids expressing the nonlipidated products TmpC* and TpD* were designated pRIT9912 and pRIT2801, respectively. In both cases, a TGC-+AGC mutation resulted in a single amino acid substitution from cysteine to serine.
To obtain a lipidated form of TmpB, plasmid pRIT4661 carrying the tmpA-tmpB operon was cut with NarI and treated with DNA polymerase (Klenow) in the presence of dCTP. The fragment was then cut with SnaBI and religated.
The plasmid expressing the lipidated TmpB* fusion product was designated pRIT9932.
All plasmid derivatives were analyzed by DNA sequencing, and it was found that the desired 1-bp substitutions in the tmpA, tmpC, and tpD genes had been achieved. However, in plasmid pRIT9932, a 132-bp deletion of the tmpB gene was found. Purification of TmpC. E. coli K-12 carrying plasmid pRIT9070 was cultured at 28°C in 7-liter fermentors in NZYM medium containing ampicillin (200 ,ug/ml). The partial 02 pressure was monitored, and the oxygen concentration was kept at 10% saturation. The pH was kept at 7.5 with 10 M NaOH. Glucose was added slowly during cultivation at a rate sufficient to maintain a glucose concentration of 1 g/liter. At 24 h postinoculation, the temperature was raised to 42°C and the culture was incubated for another 4 h at 42°C. Cells were harvested by centrifugation, resulting in a yield of approximately 135 g (wet weight) of cells. The cells were suspended in 500 ml of 150 mM NaCl and stored at -70°C in 40-ml fractions.
Frozen cells (40 ml) were thawed, lysozyme was added (1 mglml), and the mixture was incubated for 20 min at room temperature. EDTA was added to a concentration of 20 mM and incubated for 10 min at room temperature. The cells were disrupted by ultrasonic treatment by using a sonifier (B-12; Branson Sonic Power Co., Danbury, Conn.) operating at 100 W. Cellular debris was removed by centrifugation for 10 min at 8,000 x g. Membranes and other particulate material were collected by centrifugation at 20,000 x g for 20 min. The pellet was resuspended in 40 ml of 150 mM NaCl and centrifuged again for 20 min at 20,000 x g, and the pellet was suspended in 40 ml of 150 mM NaCl. This crude cell envelope preparation was then incubated for 2 h at room temperature with 0.25% N-tetradecyl-N,N-dimethylammonio-1-propanesulfonate (SB-14; Serva) in the presence of 10 mM MgCl2 and 10 mM Tris, pH 8.0, under constant stirring. This treatment solubilized about 90% of the TmpC.
After centrifugation at 20,000 x g for 30 min, the protein mixture was subjected to anion exchange (DEAE-Trisacryl; IBF) and fractions containing TmpC were pooled. TmpC was purified to near homogeneity by preparative isoelectric focusing as described previously (28) . TmpC was extracted from a gel fraction in the pH 4.5 region of the focusing gel.
Fractionation of cell envelopes of T. paUidum and E. coli. The preparation of T. pallidum and E. coli cell envelopes was done as described previously (28) . Briefly, cells were treated with lysozyme and disrupted by ultrasonic treatment, unbroken cells were removed by low-speed centrifugation, and the membranes were collected by ultracentrifugation. This membrane fraction was washed twice and used for further analysis.
The method for determining the peptidoglycan association of proteins was basically the same as that of Hazumi et al. (10) . Crude cell envelopes of T. pallidum and E. coli recombinants were prepared as described above, except that the lysozyme treatment was omitted. The cell envelope fraction was then treated with extraction buffer (10 mM Tris-HCl, 2% dithioerythritol, 2% SDS, 10% glycerol, pH 7.5) for 30 min at 60°C. The solubilized proteins were separated from the peptidoglycan fraction by centrifugation for 15 min at 13,000 x g. For SDS-PAGE analysis, samples were pretreated with lysozyme (250 ,ug/ml) or trypsin (250 ,ug/ml) or mixed directly with the SDS-PAGE sample buffer.
Processing of the lipidated and nonlipidated T. pallidum antigens. To study the posttranslational cleavage of the T. pallidum precursor molecules in E. coli, cells carrying the Fig. 1 , indicate that the tmpC gene is located between 0 and 3.2 kb on the physical map of the T. pallidum DNA insert.
To determine the direction of transcription and to obtain hyperexpression of TmpC, the heat-inducible lambda promoter PL was inserted at various sites of the TmpC plasmid DNA. The position of PL in three of the plasmids obtained and the expression of TmpC at 28 and 42°C are shown in Fig.  1 . One of these, plasmid pRIT9070, expressed TmpC at high levels at 42°C, whereas no detectable expression was found at 28°C, apparently due to binding of the A c1857 repressor, which shuts off transcription by binding to the A operator at 28°C (Fig. 2) . This indicates that the transcription of tmpC is from right to left, as depicted in Fig. 1 In an effort to elucidate the function of this lipoprotein, the translated TmpC sequence and the tmpC DNA sequence were compared with sequences from the protein data banks (Swiss-Prot v14 and GenPept v63), DNA data bases (EMBL v24 and GenBank v65), and all T. pallidum protein and DNA sequences that have been published (20) . This homology search, however, did not reveal any significant homology with other known sequences.
In vivo lipidation of TmpC. The deduced amino acid sequence of TmpC revealed a potential N-terminal signal sequence, characteristic for prokaryotic proteins that are transported across the inner membrane (15) . In addition, the four-amino-acid sequence Leu-Ile-Gly-Cys, in the C-terminal part of this signal sequence, is a motif characteristic of bacterial lipoproteins, suggesting that TmpC is lipid modified (32, 34) . In order to determine whether TmpC is indeed a lipoprotein, metabolic labeling of TmpC-producing E. coli with radioactive palmitic acid was performed. An analysis of lysates from the labeled cultures on SDS-PAGE and subsequent fluorography revealed that the cells indeed incorporated the radioactive fatty acid into the TmpC antigen (Fig.  5A, lane C) . Consistent with the presence of the hydrophobic lipid groups on TmpC, we found that TmpC partitioned in the detergent fraction after Triton X-114 extraction of T. pallidum (data not shown).
Construction of recombinants expressing homologous lipidated and nonlipidated T. pallidum proteins. To obtain pairs of homologous lipidated and nonlipidated T. pallidum proteins, we engineered the 3'-proximal sequences of the genes encoding TmpA, TmpB, TmpC, and TpD. As previously described, the leader sequences of TmpA, TmpC, and TpD carry a tetrapeptide lipidation motif containing a cysteine residue (Fig. 6 ). This cysteine is essential for recognition by signal peptidase II and for attachment of the lipid moiety. In order to obtain mutants which have lost the capacity to be lipidated, we substituted serine for this cysteine in the lipidation motif in TmpA, TmpC, and TpD. As expected, radioactive palmitic acid was not incorporated during in vivo labeling into the mutant proteins, which were designated TmpA*, TmpC*, and TpD*, respectively (Fig. 5A) .
In contrast to the above-mentioned lipoproteins, the TmpB antigen is not lipid modified (28) to the tmpB gene. As shown in Fig. 5A , radioactive palmitic acid was incorporated during in vivo labeling into the fusion product, designated TmpB*. The TmpB* protein has an apparent molecular mass of 32 kDa on SDS-PAGE gels, which is significantly less than the expected molecular mass. Sequence analysis of the TmpB* plasmid revealed that, probably because of incomplete ligation during the construction, a 132-bp deletion had occurred, resulting in a loss of the first 48 amino acids of the TmpB antigen. Analysis of lysates from E. coli producing TmpA, TmpB, TmpC, or TpD or their mutant forms on Western blots revealed that both lipidated and nonlipidated proteins retained their reactivity with polyclonal and monoclonal antibodies ( Fig. SB and 7) . Posttranslational processing of the mutant proteins. To obtain information on the effect of the leader sequence mutation on the processing of the T. pallidum antigens, E. coli cells carrying the various recombinant proteins were induced for antigen production in the presence or absence of ethanol, a compound known to inhibit the posttranslational cleavage of the signal peptide. Western blot analysis (Fig. 7) revealed that all antigens except TpD* are posttranslationally cleaved in E. coli. The processing of TmpA* and TmpC* is remarkable, as the cleavage site for signal peptidase II has been destroyed by the amino acid substitution. However, inspection of the N-terminal part of these proteins revealed an alternate processing site for signal peptidase I in both proteins, which might explain the processing of the nonlipidated antigens (Fig. 6 ). There is precedence for alternate cleavage by signal peptidase I of lipoproteins if the signal peptidase II cleavage site is inactivated by mutation (34) . Although a weak alternate cleavage site is also present in the TpD antigen, no processing of TpD* was observed. Interestingly, the non-lipid-modified TpD* antigen did not display the heterogeneous mobility on SDS-PAGE characteristic of TpD, suggesting that posttranslational modification is responsible for the heterogeneity (Fig. SB and 7) .
Although the presence of peptidoglycan has been demonstrated in T. pallidum (23) , no data have been published on the association of proteins or lipoproteins with this matrix structure. Cell envelopes of E. coli producing the lipoprotein TmpA, TmpC, or TpD and cell envelopes of T. pallidum were treated with SDS at 60°C, and the nonsolubilized peptidoglycan skeleton with the associated protein was spun down. The soluble and particulate fractions were then analyzed on SDS-PAGE gels and by Western blotting. To release any proteins covalently bound to the peptidoglycan, the particulate fraction was treated with either lysozyme or trypsin. No T. pallidum proteins were found to be associated with the SDS-insoluble, lysozyme-treated fraction, either by gold staining of proteins electroblotted after SDS-PAGE (data not shown) or by immunoblotting with polyclonal anti-T. pallidum serum (Fig. 8) 
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GAGTACGTGCCTAGTTTGTCTGCGTTTGCAGATGAGAATATGGGGCTCGTGGTAGCATGCGGC
TTCATCGTTGGCATGGAGCTGGGTATGATGCCTCTCTTTGAAGCGGGTTTTGAAGCGGGGGTT 630 (data not shown). None of the analyzed recombinant lipoproteins, but also none of the other T. pallidum antigenic proteins, seems to be associated with the peptidoglycan fraction (Fig. 8) .
Absorption with lipidated and nonlipidated antigens. In order to obtain information on whether the development of VDRL antibodies during syphilis was caused by T. pallidum lipoproteins, several absorption experiments were performed. For this purpose, anti-T. pallidum antibodies, from experimentally infected rabbits, or anti-TmpA and antiTmpC antisera, obtained by immunizing rabbits with purified TmpA or TmpC, were absorbed with either lipidated or nonlipidated TmpA and TmpC and the remaining nonabsorbed antibodies were analyzed by immunoblotting. The absorption procedures, with lipidated or nonlipidated antigen, removed all reactivity against the lipidated forms of TmpA and TmpC (Table 2 ). An analysis of sera from rabbits immunized with lipidated, purified recombinant TmpA or TmpC showed that these lipoproteins elicited no VDRLreactive antibodies. In addition, the lipidated fusion product TmpB*, carrying the TmpA signal sequence, does not react with antibodies directed against lipidated TmpA nor does it elicit VDRL antibodies after the immunization of rabbits.
DISCUSSION
In this study, we report the DNA sequence of a cloned T. pallidum gene encoding the 35-kDa lipoprotein TmpC.
By replacing the treponemal tmpC promoter by the thermoinducible lambda promoter, a high level of temperaturedependent TmpC production was obtained. This enabled us to isolate and purify the TmpC antigen for use in an ELISA to determine its usefulness for the serodiagnosis of syphilis.
Serum samples from untreated syphilis patients in different stages of the disease and from antibiotic-treated patients were investigated. Although the serum samples from untreated secondary syphilis patients were reactive without exception, a minority (46%) of the serum samples from untreated patients in the primary stage displayed reactivity with the TmpC antigen. In addition, 25% of the serum samples from early-latent-stage syphilis patients were nonreactive in the TmpC ELISA. The relatively poor reactivity of samples from primary and latent syphilis patients suggests that the antibody response against TmpC occurs late in infection and that the antibody level declines during latency. Apparently, TmpC is poorly presented to the immune system during natural infection with T. pallidum. This is probably not due to the intrinsically poor immunogenicity of TmpC, because recombinant TmpC is extremely immunogenic in rabbits, evoking a strong antibody response even after a single vaccination with this antigen without adjuvant (27) .
Only a few serum samples from antibiotic-treated patients were reactive with TmpC. This suggests that the anti-TmpC antibody level, similar to that of antibodies reactive in the VDRL test and the level of anti-TmpA antibodies, drops after antibiotic treatment. In contrast, antibodies measured in the fluorescent treponemal antibody (FTA)-ABS and the TPHA generally remain detectable for many years after treatment.
Unlike antibodies from rabbits immunized with purified lipidation, the signal peptidase II cleaves off the lipoprotein signal sequence, leaving an N-terminal cysteine, which is then linked to a third fatty acid via an amide bond. The TmpA (29) , TpD (29, 30) , and 15-kDa (21) T. pallidum antigens also seem to follow this lipid modification pathway, which was first described for the major outer membrane lipoprotein in E. coli, Braun's lipoprotein (3, 34) . Other pathways for protein lipidation might exist in T. pallidum, because the 47-kDa antigen of T. pallidum, despite the lack of a characteristic signal sequence with the lipidation motif, has also been shown to be lipid modified in both T. pallidum and E. coli (5, 11) .
The signal sequences of four T. pallidum protein genes were genetically manipulated, resulting in strains that enabled the isolation of TmpA, TmpB, TmpC, and TpD as lipidated and nonlipidated antigens. These antigens will be used for further studies on the role of lipid modification in the regulation of the immune response to infections with T. function in maintaining the shape and rigidity of the cell. Braun's lipoprotein is anchored into the outer membrane by means of the N-terminal lipid moiety and is coupled to the peptidoglycan layer by means of a covalent bond between a C-terminal lysine of the protein and the meso-diaminopimelic acid of the peptidoglycan. As expected from the lack of a C-terminal lysine in TmpA, TmpC, and TpD, none of these lipoproteins was found to be covalently coupled to the peptidoglycan layer in T. pallidum or in E. coli. In most gram-negative bacteria, a number of other proteins, mainly porins, are also strongly, but not covalently, associated with the peptidoglycan layer. In addition to their porin properties, these proteins also contribute to the stability of the bacterial cell. Such proteins, however, could not be detected in the peptidoglycan fraction of T. pallidum, suggesting an unusually low concentration or absence of peptidoglycan-associated proteins. This finding would be consistent with the observation that the T. pallidum outer membrane contains a paucity of proteins (24) . Together with the lack of lipopolysaccharide, the lack or paucity of outer membrane proteins such as Braun's lipoprotein and porins might explain the extreme fragility of T. pallidum.
The lipid moiety on bacterial lipoproteins possesses strong immune-modulating properties. A synthetically prepared dipeptide-lipid conjugate (Pam3-Cys-Ser), in which three palmitic acid molecules are bound to cysteine in a fashion similar to the bacterial lipoprotein, can be covalently coupled to peptides. It has been shown that linkage of Pam3-Cys-Ser to peptides greatly enhances the antibody response to these peptides, making coupling to large carrier molecules and the addition of adjuvants unnecessary (13) . A recent study shows that Pam3-Cys-Ser-conjugated peptides can also elicit strong, protective cytotoxic T-cell responses (6) . These findings show that the lipidation of proteins potentiates both humoral and cellular immune responses against these proteins. The mechanism for this potentiation of an immune response by covalently attached lipids is unclear. Possibly, the lipid moiety stabilizes the peptide, extending the half-life of the peptide. Alternatively, lipid modification might facilitate the association of the peptide with the major histocompatibility complex molecules and the insertion into the membrane of the antigen-presenting cell. Whatever the mechanism, the possible stimulation of an immune response by treponemal lipoproteins makes these antigens particularly interesting for the study of the immune response in patients with syphilis. The availability of pairs of lipidated and nonlipidated T. pallidum antigens described in this study will make possible future studies on the role of lipid modification in the immune response to T. pallidum infection.
